Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05DDN
|
|||
Former ID |
DCL000835
|
|||
Drug Name |
HCV-796
|
|||
Synonyms |
Nesbuvir; Nesbuvir (USAN); 79Z
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Discontinued in Phase 2 | [1] | |
Company |
ViroPharma; Wyeth
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H23FN2O5S
|
|||
Canonical SMILES |
CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F
|
|||
InChI |
1S/C22H23FN2O5S/c1-24-22(27)20-17-11-16(13-3-4-13)18(25(9-10-26)31(2,28)29)12-19(17)30-21(20)14-5-7-15(23)8-6-14/h5-8,11-13,26H,3-4,9-10H2,1-2H3,(H,24,27)
|
|||
InChIKey |
WTDWVLJJJOTABN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 691852-58-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
16663606, 24464334, 24716663, 42703274, 57269517, 57269518, 79167686, 96025634, 99443709, 103746791, 134223834, 134339301, 134339626, 135252257, 137095430, 139725969, 152159606, 152258602, 160647436, 160968321, 170482427, 170482428, 174007343, 185990490, 198942728, 223436388, 224170262, 228617599, 247953675
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hepatitis C virus RNA-directed RNA polymerase (HCV NS5B) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging drugs for hepatitis C. Expert Opin Emerg Drugs. 2008 Mar;13(1):1-19. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.